Key statistics
On Friday, LivaNova PLC (L2IV34:SAO) closed at 42.56, 0.00% above its 52-week low of 42.56, set on Jan 16, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 42.56 |
|---|---|
| High | 42.56 |
| Low | 42.56 |
| Bid | 42.72 |
| Offer | 43.16 |
| Previous close | 42.56 |
| Average volume | -- |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jan 16 2026 20:54 GMT.
More ▼
Press releases
- LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results
- LivaNova to Present at J.P. Morgan Healthcare Conference in January
- LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting
- LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
- LivaNova to Present at Piper Sandler Healthcare Conference in December
- LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
More ▼
